Table 3.

Differences in symptom scores of the PLD-Q 6 months after therapy between responders and non-responders

Symptom	Responder n = 23		Non-responder n = 11
	Change in score	p value*	Change in score	p value
Fullness	-2 (-5 to 0)	0.002	-1 (-3 to -1)	0.040
Lack of appetite	-4 (-6 to -2)	0.042	-3 (-4 to 1)	0.330
Early satiety	-1 (-4 to 0)	0.004	-2 (-3 to 0)	0.071
Nausea	2 (2 to 4)	< 0.001	4 (2 to 4)	0.007
Pain/pressure rib cage	-4 (-5 to -2)	< 0.001	-3 (-4 to -1)	0.016
Pain in side	-3 (-6 to -2)	< 0.001	0 (-3 to 1)	0.167
Abdominal pain	-2 (-3 to -1)	< 0.001	0 (-2 to 1)	0.786
Shortness of breath	-2 (-4 to -1)	< 0.001	0 (-4 to 2)	0.497
Limited mobility	-3 (-4 to -1)	< 0.001	0 (-3 to 1)	0.750
Tiredness	-2 (-2 to 0)	0.002	0 (-2 to 1)	0.586
Fear/anxiety future	0 (-2 to 0)	0.217	1 (0 to 3)	0.102
Dissatisfaction abdomen size	-1 (-3 to 0)	0.027	-1 (-2 to 0)	0.149
Problems with intercourse	-1 (-4 to 0)	0.018	0 (-1 to 0)	0.180

Changes in PLD-Q symptoms presented as median (IQR). *p value of pre- and post-treatment scores using Wilcoxon signed-rank test